Opengamma is a developer of market risk management platform for financial services firms which is designed to optimize their businesses in the evolving OTC markets.
PRODUCTS & SERVICES:
OpenGamma helps financial services industry by providing an open-source platform called Strata which enables derivatives risk management and analytics solutions specifically for the use in the derivatives OTC markets.
The company refers to its solutions as "Risk as a Service" that encompasses ETD & OTC margin calculations, bilateral OTC margining, and derivatives MTM & Greeks calculation.
It allows users to use Strata and create customize solutions for their analytics platform.
The company is planning to offer a cost-effective and nimble alternative to legacy, enterprise-wide platforms by using an innovative range of software-as-a-service (SaaS) solutions based on an open source library of standardized derivatives pricing and risk models.
MEDICI analysts will analyze OpenGamma soon
Insufficient information for accurate analysis
DATE OF LAST FUNDING:
TOTAL FUNDING COMMENT:
The company will use the funds to address the increasing demand from financial institutions for more efficient use of capital and technology resources. (Feb. 2017)
$2.15 Millions Closed: Jul 2009
$6 Millions Closed: Jan 2011
$15 Million Closed: Aug 2012
$13.3 Millions Closed: Oct 2016
$10 Million Closed: Apr 2019
$1 Million Closed: Jan 2017
Venture funding: $1 M(Feb 2017).
Series D: $13.3 M (Oct 2016).
Debt Financing: $2.25 M (Feb 2016).